Hansa Biopharma AB 2021 Annual Report with Sustainability Disclosures
Company: Hansa Biopharma AB
Sector: Manufacturing
Country: Sweden
Year: 2021
Type: Annual Report with Sustainability Disclosures
Pages: 156
The report describes Hansa Biopharma's transition to a fully integrated commercial-stage company in 2021, including the first commercial sale of Idefirix® and expanded European market access. It also documents the company's first materiality analysis and formalized ESG strategy, organized around healthy patients, healthy business, and healthy planet. Environmental disclosures include initial Scope 2 and Scope 3 emissions reporting and 63% renewable energy use, while the workforce section reports 131 year-end FTEs, 33% women on the Board, and a Great Place to Work certification.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.